Milnacipran Hydrochloride Patent Expiration
Milnacipran Hydrochloride is Used for managing fibromyalgia. It was first introduced by Abbvie Inc
Milnacipran Hydrochloride Patents
Given below is the list of patents protecting Milnacipran Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Savella | US7994220 | Milnacipran for the long-term treatment of fibromyalgia syndrome | Sep 19, 2029 | Abbvie |
| Savella | US6602911 | Methods of treating fibromyalgia |
Jan 14, 2023
(Expired) | Abbvie |
| Savella | US6992110 | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
Nov 05, 2021
(Expired) | Abbvie |
| Savella | US7888342 | Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
Nov 05, 2021
(Expired) | Abbvie |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Milnacipran Hydrochloride's patents.
Latest Legal Activities on Milnacipran Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Milnacipran Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent Critical
| 20 Mar, 2023 | US7888342 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 11 Jan, 2023 | US7994220 |
| Maintenance Fee Reminder Mailed Critical
| 03 Oct, 2022 | US7888342 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 11 Feb, 2019 | US7994220 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Aug, 2018 | US7888342 |
| Patent Term Extension Certificate Critical
| 24 Aug, 2012 | US6602911 |
| Notice of Final Determination -Election Required | 23 Apr, 2012 | US6602911 |
| Notice of Final Determination -Election Required | 23 Apr, 2012 | US6992110 |
| Patent Issue Date Used in PTA Calculation Critical
| 09 Aug, 2011 | US7994220 |
| Recordation of Patent Grant Mailed Critical
| 09 Aug, 2011 | US7994220 |
Milnacipran Hydrochloride's Family Patents
